JPRN-UMIN000014650已完成2 期
Intranasal oxytocin in the treatment of schizophrenia - Intranasal oxytocin in the treatment of schizophrenia
the ethics committee of the National Center of Neurology and Psychiatry0 个研究点目标入组 20 人开始时间: 2014年8月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
Oxytocin significantly reduced scores on the positive and negative syndrome scale, especially on the negative symptoms. As for cognition, there was an improvement of the verbal fluency. Furthermore, the change of the negative score in positive and negative syndrome scale showed a negative correlation with the gray matter volumes of the right insula and left cingulate cortex.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 64years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Participants were excluded if they had a prior medical history of central nervous system disease or severe head injury, pregnancy or the possibility of pregnancy, or if they met the criteria for substance abuse or dependence.
研究者
相似试验
终止
不适用
Antipsychotic Effects of OxytocinSchizophreniaNCT01621737University of California, San Diego42
已完成
3 期
The impact of Oxytocin (OT) on social cogntion in Schizophrenia.Mental Health - SchizophreniaSchizophreniaACTRN12609000528257niversity of Sydney40
已完成
不适用
Oxytocin and Social Decision Making in SchizophreniaSchizophreniaNCT04176835National Institute of Mental Health and Neuro Sciences, India55
已完成
2 期
intranasal oxytocin in the treatment of schizophreniaschizophrenia.schizophreniaIRCT201202251556N35Tehran University of Medical Sciences40
已完成
2 期
Oxytocin as Adjunctive Treatment of SchizophreniaSchizophreniaNCT01568528Emory University39